Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins. | Biophys Physicobiol | 2021 | 34745807 | PubTator, text mining | PubMed |
| Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma. | J Healthc Eng | 2021 | 34745496 | PubTator, text mining | PubMed |
| Macrophages M1-Related Prognostic Signature in Hepatocellular Carcinoma. | J Oncol | 2021 | 34745260 | PubTator, text mining | PubMed |
| Bioinformatics analysis reveals the roles of cytoskeleton protein transgelin in occurrence and development of proteinuria. | Transl Pediatr | 2021 | 34733666 | PubTator, text mining | PubMed |
| An 11-gene signature for the prediction of systemic recurrences in colon adenocarcinoma. | Gastroenterol Rep (Oxf) | 2021 | 34733531 | PubTator, text mining | PubMed |
| Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21. | Sci Rep | 2021 | 34728715 | PubTator, text mining | PubMed |
| A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma. | Dis Markers | 2021 | 34721731 | PubTator, text mining | PubMed |
| Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer. | Sci Rep | 2021 | 34716381 | PubTator, text mining | PubMed |
| Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics. | Cancer Cell Int | 2021 | 34715855 | PubTator, text mining | PubMed |
| The Relationship Between Mesenchymal Stem Cells and Tumor Dormancy. | Front Cell Dev Biol | 2021 | 34712663 | PubTator, text mining | PubMed |
| A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer. | Onco Targets Ther | 2021 | 34707365 | PubTator, text mining | PubMed |
| The Emerging Roles of Long Noncoding RNAs as Hallmarks of Lung Cancer. | Front Oncol | 2021 | 34692550 | PubTator, text mining | PubMed |
| Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy. | Mol Biol Rep | 2021 | 34687392 | PubTator, text mining | PubMed |
| Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment. | Cells | 2021 | 34685725 | PubTator, text mining | PubMed |
| N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor. | Cells | 2021 | 34685629 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Genes Involved in Plant Defense Response to the Cucumber Green Mottle Mosaic Virus Infection. | Life (Basel) | 2021 | 34685435 | PubTator, text mining | PubMed |
| CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes. | Stem Cell Reports | 2021 | 34678208 | PubTator, text mining | PubMed |
The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy : Gene involvement in the mechanisms of inflammation and scarring in kidney biopsy of IgAN patients. | Semin Immunopathol | 2021 | 34674036 | PubTator, text mining | PubMed |
| Differential expression and hypoxia-mediated regulation of the N-myc downstream regulated gene family. | FASEB J | 2021 | 34665878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=47